81 FR 41586 - National Institute of Neurological Disorders and Stroke; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 123 (June 27, 2016)

Page Range		41586-41586
FR Document		2016-15068

Federal Register, Volume 81 Issue 123 (Monday, June 27, 2016)

[Federal Register Volume 81, Number 123 (Monday, June 27, 2016)]
[Notices]
[Page 41586]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-15068]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
National Advisory Neurological Disorders and Stroke Council.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable materials, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Neurological Disorders and 
Stroke Council.
    Date: September 15-16, 2016.
    Open: September 15, 2016, 8:00 a.m. to 2:30 p.m.
    Agenda: Report by the Director, NINDS; Report by the Associate 
Director for Extramural Research; Administrative and Program 
Developments; and an Overview of the NINDS Intramural Program.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, 6th Floor, Conference Room 10, Bethesda, MD 20892.
    Closed: September 15, 2016, 2:30 p.m. to 4:45 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, 6th Floor, Conference Room 10, Bethesda, MD 20892.
    Closed: September 15, 2016, 4:45 p.m. to 5:15 p.m.
    Agenda: To review and evaluate the Division of Intramural 
Research Board of Scientific Counselors' Reports.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, 6th Floor, Conference Room 10, Bethesda, MD 20892.
    Closed: September 16, 2016, 8:00 a.m. to 11:00 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, 6th Floor, Conference Room 10, Bethesda, MD 20892.
    Contact Person: Robert Finkelstein, Ph.D., Director of 
Extramural Research, National Institute of Neurological Disorders 
and Stroke, NIH, 6001 Executive Blvd., Suite 3309, MSC 9531, 
Bethesda, MD 20892, (301) 496-9248.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institute's/Center's home 
page: http://www.ninds.nih.gov, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS).

    Dated: June 21, 2016.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-15068 Filed 6-24-16; 8:45 am]
 BILLING CODE 4140-01-P

41586 Federal Register / Vol. 81, No. 123 / Monday, June 27, 2016 / Notices

Integrated analysis of miRNA, DEPARTMENT OF HEALTH AND Contact Person: Robert Finkelstein, Ph.D.,
mRNAs, and lncRNAs to assess HUMAN SERVICES Director of Extramural Research, National
Institute of Neurological Disorders and
radiation exposure after mass-casualty
National Institutes of Health Stroke, NIH, 6001 Executive Blvd., Suite
incidents could provide a valuable tool 3309, MSC 9531, Bethesda, MD 20892, (301)
in identifying biomarkers, and in the 496–9248.
National Institute of Neurological
development and appropriate Any interested person may file written
Disorders and Stroke; Notice of
implementation of effective medical comments with the committee by forwarding
Meeting
countermeasures. This application the statement to the Contact Person listed on
could potentially also be used to Pursuant to section 10(d) of the this notice. The statement should include the
immediately detect, and therefore Federal Advisory Committee Act, as name, address, telephone number and when
applicable, the business or professional
circumvent or mitigate non-specific amended (5 U.S.C. App.), notice is
affiliation of the interested person.
injury from cancer radiotherapy hereby given of a meeting of the In the interest of security, NIH has
treatments. National Advisory Neurological instituted stringent procedures for entrance
Disorders and Stroke Council. onto the NIH campus. All visitor vehicles,
Potential Commercial Applications:
The meeting will be open to the including taxicabs, hotel, and airport shuttles
• Diagnostic for radiation exposure, public as indicated below, with will be inspected before being allowed on
including for therapeutic procedures. attendance limited to space available. campus. Visitors will be asked to show one
Individuals who plan to attend and form of identification (for example, a
Value Proposition: government-issued photo ID, driver’s license,
need special assistance, such as sign
• Blood-based biomarker assay for or passport) and to state the purpose of their
language interpretation or other visit.
circulating miRNAs.
reasonable accommodations, should Information is also available on the
• Could be developed as part of notify the Contact Person listed below Institute’s/Center’s home page: http://
point-of-care and high-throughput in advance of the meeting. www.ninds.nih.gov, where an agenda and
screening platforms. The meeting will be closed to the any additional information for the meeting
• Immediate medical care based on public in accordance with the will be posted when available.
amount of radiation exposure is critical provisions set forth in sections (Catalogue of Federal Domestic Assistance
for giving appropriate care to affected 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Program Nos. 93.853, Clinical Research
as amended. The grant applications and Related to Neurological Disorders; 93.854,
individuals. Biological Basis Research in the
the discussions could disclose
Development Stage: confidential trade secrets or commercial Neurosciences, National Institutes of Health,
HHS).
In-vivo testing. property such as patentable materials,
and personal information concerning Dated: June 21, 2016.
Inventor(s):
individuals associated with the grant Sylvia L. Neal,
Molykutty Aryankalayil (NCI), applications, the disclosure of which Program Analyst, Office of Federal Advisory
Norman Coleman (NCI), Adeola would constitute a clearly unwarranted Committee Policy.
Makinde (NCI). invasion of personal privacy. [FR Doc. 2016–15068 Filed 6–24–16; 8:45 am]
Intellectual Property: Name of Committee: National Advisory BILLING CODE 4140–01–P

HHS Reference No. E–066–2015/0– Neurological Disorders and Stroke Council.
US–01 US Provisional Application 62/ Date: September 15–16, 2016.
Open: September 15, 2016, 8:00 a.m. to DEPARTMENT OF HEALTH AND
244,044 (HHS Reference No. E–066– 2:30 p.m. HUMAN SERVICES
2016/0–US–01) filed October 20, 2015 Agenda: Report by the Director, NINDS;
entitled ‘‘Biomarker signature Report by the Associate Director for National Institutes of Health
development: microRNAs as Extramural Research; Administrative and
biodosimetry markers’’ Program Developments; and an Overview of Center for Scientific Review; Notice of
the NINDS Intramural Program. Closed Meetings
Collaboration Opportunity: Place: National Institutes of Health,
Researchers at the NCI seek parties Building 31, 31 Center Drive, 6th Floor, Pursuant to section 10(d) of the
interested in licensing or co- Conference Room 10, Bethesda, MD 20892. Federal Advisory Committee Act, as
development for microRNA biomarker Closed: September 15, 2016, 2:30 p.m. to amended (5 U.S.C. App.), notice is
signatures as biodosimetry markers. 4:45 p.m. hereby given of the following meetings.
Agenda: To review and evaluate grant The meetings will be closed to the
Contact Information: applications. public in accordance with the
Requests for copies of the patent Place: National Institutes of Health, provisions set forth in sections
application or inquiries about licensing, Building 31, 31 Center Drive, 6th Floor,
Conference Room 10, Bethesda, MD 20892.
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
research collaborations, and co- as amended. The grant applications and
Closed: September 15, 2016, 4:45 p.m. to
development opportunities should be 5:15 p.m. the discussions could disclose
sent to John D. Hewes, Ph.D., email: Agenda: To review and evaluate the confidential trade secrets or commercial
john.hewes@nih.gov or phone: 240–276– Division of Intramural Research Board of property such as patentable material,
5515. Scientific Counselors’ Reports. and personal information concerning
Place: National Institutes of Health, individuals associated with the grant
Dated: June 20, 2016. Building 31, 31 Center Drive, 6th Floor,
mstockstill on DSK3G9T082PROD with NOTICES

applications, the disclosure of which
John D. Hewes, Conference Room 10, Bethesda, MD 20892. would constitute a clearly unwarranted
Technology Transfer Specialist, Technology Closed: September 16, 2016, 8:00 a.m. to
11:00 a.m.
invasion of personal privacy.
Transfer Center, National Cancer Institute.
Agenda: To review and evaluate grant Name of Committee: AIDS and Related
[FR Doc. 2016–15059 Filed 6–24–16; 8:45 am]
applications. Research Integrated Review Group; AIDS
BILLING CODE 4140–01–P Place: National Institutes of Health, Molecular and Cellular Biology Study
Building 31, 31 Center Drive, 6th Floor, Section.
Conference Room 10, Bethesda, MD 20892. Date: July 18, 2016.

VerDate Sep<11>2014 20:12 Jun 24, 2016 Jkt 238001 PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 E:\FR\FM\27JNN1.SGM 27JNN1

Document Created: 2016-06-25 02:07:14
Document Modified: 2016-06-25 02:07:14

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		September 15-16, 2016.
FR Citation		81 FR 41586

81 FR 41586 - National Institute of Neurological Disorders and Stroke; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 123 (June 27, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health